manilatimes41 分钟
Altimmune Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a ...
GAITHERSBURG, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical ...